Status:

RECRUITING

Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)

Lead Sponsor:

National Cancer Centre, Singapore

Collaborating Sponsors:

SingHealth Duke-NUS Academic Medical Centre

Conditions:

Solid Tumor

Eligibility:

All Genders

21-99 years

Brief Summary

This observational study aims to assess the outcomes in patients with advanced treatment refractory cancers with matched molecular/precision therapy as per their molecular profiling results after disc...

Detailed Description

The patient will be observed clinically after informed consent has been obtained. Patients may require more frequent assessment or additional procedures as clinically necessary or as required by the p...

Eligibility Criteria

Inclusion

  • Is equal to or greater than 21 years of age;
  • Histologic or cytologic confirmed advanced solid tumours;
  • Patients who have received and failed all standard anticancer therapy (if available) or are unsuitable for further standard anticancer therapy. Cancers with a poor prognosis or low expected response rate to standard treatment (as judged by the investigator on the basis of available evidence) may be screened with respect to an earlier line of treatment;
  • Ability to understand and the willingness to provide written informed consent.

Exclusion

  • Specific contraindications to exposure to the off-label or non-standard therapy (as defined by the product label);
  • Other comorbid conditions that may compromise assessing key outcomes or, in the judgement of the clinician, limit the ability of the patient to comply with the protocol.

Key Trial Info

Start Date :

September 12 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 12 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06956248

Start Date

September 12 2024

End Date

March 12 2027

Last Update

May 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cancer Centre, Singapore

Singapore, Singapore, 168583